To further investigate the mechanism of GSK3β, 40 μM cycloheximide (CHX) was introduced into FOXO1-overexpressing NPC cells, and we found that MYH9-mediated GSK3β proteins had shorter half-lives than proteins in the control group. This evidence concerns the gene FOXO1 and nasopharyngeal carcinoma.